Lv1
70 积分 2022-11-06 加入
Bone mineralization: from tissue to crystal in normal and pathological contexts
1年前
已完结
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
1年前
已完结
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges
1年前
已完结
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
1年前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
1年前
已完结
A Revolution in the Treatment of Obesity
1年前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
1年前
已完结
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
1年前
已完结
Applications of SGLT2 inhibitors beyond glycaemic control
1年前
已完结
Medications for Obesity: A Review
1年前
已完结
皖公网安备34019202002308
